Irhythm Holdings (IRTC) closed at $90.22 on November 6, 2026, down 30.7% from the previous close, on volume of 5,416,990 shares (30-day average 495,916).
Data as of November 6, 2026.
PRNewswire (Fri, 6-Nov 4:43 PM ET)
iRhythm plunges after Q3 miss, Zio MCT delay
Seeking Alpha News (Fri, 6-Nov 1:07 PM ET)
Oppenheimer Sticks to Their Buy Rating for Irhythm Technologies (IRTC)
TipRanks (Fri, 6-Nov 10:02 AM ET)
Irhythm Technologies (IRTC) Gets a Buy from Wells Fargo
TipRanks (Fri, 6-Nov 9:43 AM ET)
Piper Sandler Remains a Buy on Irhythm Technologies (IRTC)
TipRanks (Fri, 6-Nov 9:22 AM ET)
iRhythm Holdings to Participate in Upcoming Investor Conferences
Globe Newswire (Fri, 6-Nov 9:15 AM ET)
iRhythm’s Strong Core Growth and Profitability Support Buy Despite Price Target Cut to $170
TipRanks (Fri, 6-Nov 9:09 AM ET)
IRTC: Temporary Zio AT Weakness Prompts Price-Target Cut to $150, but Durable Growth Supports a Buy
TipRanks (Fri, 6-Nov 9:09 AM ET)
At a glance: stocks gapping down premarket
Seeking Alpha News (Fri, 6-Nov 6:54 AM ET)
iRhythm Technologies Non-GAAP EPS of -$0.90 misses by $0.95, revenue of $221.6M misses by $0.63M
Seeking Alpha News (Thu, 5-Nov 4:36 PM ET)
iRhythm Holdings Inc is a digital healthcare company that creates trusted solutions that detect, predict, and prevent disease. Its principal business is the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services that it believes allow clinicians to diagnose certain arrhythmias quicker and with greater efficiency than other services that rely on traditional technology. Each Zio System combines an FDA-cleared and CE-marked, wire-free, patch-based, 14-day wearable biosensor that continuously records electrocardiogram (ECG) data with a proprietary, FDA-cleared, CE-marked cloud-based data analytic software to help physicians monitor patients and diagnose arrhythmias.
Irhythm Holdings trades on the NASDAQ stock market under the symbol IRTC.
As of November 6, 2026, IRTC stock price declined to $90.22 with 5,416,990 million shares trading.
IRTC has a beta of 0.78, meaning it tends to be less sensitive to market movements. IRTC has a correlation of 0.06 to the broad based SPY ETF.
IRTC has a market cap of $2.96 billion. This is considered a Mid Cap stock.
Last quarter Irhythm Holdings reported $222 million in Revenue and $.82 earnings per share. This fell short of revenue expectation by $-649,952 and exceeded earnings estimates by $.78.
In the last 3 years, IRTC traded as high as $212.00 and as low as $55.92.
The top ETF exchange traded funds that IRTC belongs to (by Net Assets): VTI, IWM, VB, VBK, VXF.
IRTC has underperformed the market in the last year with a price return of -50.0% while the SPY ETF gained +9.6%. IRTC has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -27.5% and -24.6%, respectively, while the SPY returned -4.2% and -3.8%, respectively.
IRTC support price is $126.87 and resistance is $133.51 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that IRTC shares will trade within this expected range on the day.